|
Re: Resverlogix Announces $13 Million Private Placement
|
6
|
Resverlogix Corp.
|
Oct 06, 2020 01:01PM
|
|
Re: Resverlogix Announces $13 Million Private Placement
|
3
|
Resverlogix Corp.
|
Oct 07, 2020 11:18AM
|
|
Re: Resverlogix Announces Apabetalone Prior to SARS-CoV-2 (COVID-19) Exposure Reduces Viral Infection – Confirms Plans for COVID-19 Clinical Trial
|
5
|
Resverlogix Corp.
|
Dec 22, 2020 09:26AM
|
|
Re: Resverlogix Announces Apabetalone Prior to SARS-CoV-2 (COVID-19) Exposure Reduces Viral Infection – Confirms Plans for COVID-19 Clinical Trial
|
3
|
Resverlogix Corp.
|
Dec 22, 2020 09:38AM
|
|
Re: Resverlogix Announces Apabetalone Prior to SARS-CoV-2 (COVID-19) Exposure Reduces Viral Infection – Confirms Plans for COVID-19 Clinical Trial
|
2
|
Resverlogix Corp.
|
Dec 22, 2020 09:58AM
|
|
Re: Resverlogix Announces Change to its Board of Directors
|
4
|
Resverlogix Corp.
|
Dec 11, 2019 09:49AM
|
|
Re: Resverlogix Announces Conversion of US$12 Million Debenture Strengthening Balance Sheet
|
8
|
Resverlogix Corp.
|
Oct 14, 2020 08:24AM
|
|
Re: Resverlogix Announces Corporate Update Conference Call & Webcast on June 10, 2020 and Upcoming Presentation at the 57th ERA-EDTA Virtual Congress on
|
3
|
Resverlogix Corp.
|
Jun 07, 2020 10:26AM
|
|
Re: Resverlogix Announces Corporate Update Conference Call...
|
2
|
Resverlogix Corp.
|
Jun 05, 2020 08:01PM
|
|
Re: Resverlogix Announces Corporate Update Conference Call...
|
3
|
Resverlogix Corp.
|
Jun 05, 2020 08:19PM
|
|
Re: Resverlogix Announces Corporate Update Conference Call...
|
3
|
Resverlogix Corp.
|
Jun 05, 2020 09:00PM
|
|
Re: Resverlogix Announces Loan Reduction and Extension
|
7
|
Resverlogix Corp.
|
Aug 02, 2019 12:29PM
|
|
Re: Resverlogix Announces New Insights into the Mechanism of Apabetalone's Cardioprotective Benefit in Chronic Kidney Disease Patients
|
3
|
Resverlogix Corp.
|
Jun 13, 2023 12:33PM
|
|
Re: RESVERLOGIX ANNOUNCES PUBLICATION OF KEY APABETALONE STUDY BETONMACE IN THE JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
|
8
|
Resverlogix Corp.
|
Apr 01, 2020 11:37AM
|
|
Re: RESVERLOGIX ANNOUNCES PUBLICATION OF KEY APABETALONE STUDY BETONMACE IN THE JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
|
3
|
Resverlogix Corp.
|
Apr 01, 2020 12:22PM
|
|
Re: RESVERLOGIX ANNOUNCES PUBLICATION OF KEY APABETALONE STUDY BETONMACE IN THE JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
|
4
|
Resverlogix Corp.
|
Apr 01, 2020 12:31PM
|
|
Re: RESVERLOGIX ANNOUNCES PUBLICATION OF KEY APABETALONE STUDY BETONMACE IN THE JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
|
2
|
Resverlogix Corp.
|
Apr 01, 2020 01:28PM
|
|
Re: RESVERLOGIX ANNOUNCES PUBLICATION OF KEY APABETALONE STUDY BETONMACE IN THE JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
|
3
|
Resverlogix Corp.
|
Apr 01, 2020 01:59PM
|
|
Re: RESVERLOGIX ANNOUNCES PUBLICATION OF KEY APABETALONE STUDY BETONMACE IN THE JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
|
3
|
Resverlogix Corp.
|
Apr 01, 2020 02:55PM
|
|
Re: RESVERLOGIX ANNOUNCES PUBLICATION OF KEY APABETALONE STUDY BETONMACE IN THE JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
|
5
|
Resverlogix Corp.
|
Mar 31, 2020 05:27PM
|
